This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (18) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Weikop, P. Articles by Scheel-Krüger, J. Search for Related Content PubMed PubMed Citation Articles by Weikop, P. Articles by Scheel-Krüger, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CYCLOHEXANOL PRAZOSIN HYDROCHLORIDE VENLAFAXINE HYDROCHLORIDE Social Bookmarking                         What's this?

The Role of 1- and 2-Adrenoreceptors on Venlafaxineinduced Elevation of Extracellular Serotonin, Noradrenaline and Dopamine Levels in the Rat Prefrontal Cortex and Hippocampus

Department of Microdialysis, NeuroSearch A/S, Ballerup, Denmarkpiw{at}neurosearch.dk

J. Kehr

Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden

J. Scheel-Krüger

Department of Pharmacology NeuroSearch A/S, Ballerup, Denmark

The role of adrenergic ₁- and ₂-adrenoreceptors in augmentation of venlafaxine-induced elevation of extracellular serotonin (5-HT),noradrenaline (NA) and dopamine (DA) levels in the rat prefrontal cortex (PFC) and hippocampus (HIPP) was studied by in vivo microdialysis in anaesthetized rats. The ₁-adrenoreceptor antagonist prazosin given alone (0.3 mg/kg, s.c.) induced only a moderate reduction of hippocampal 5-HT and NA levels. The ₂-adrenoreceptor antagonistidazoxan (1.5 mg/kg, s.c.) causes moderate increases in the levels of 5-HT and DA in the PFC. The mixed 5-HT and NA reuptake inhibitor venlafaxine (10 mg/kg, i.p.) increased the efflux of 5-HT, NA and DA almost equally, to approximately 200% of the control levels in the PFC. The levels of 5-HT increased to 310%, an effect approximately twice the effect on NA in the HIPP. Venlafaxine also produced a moderate increase in DA levels in the PFC but had no effect in the HIPP. Pre-treatment with prazosin caused a significant attenuation of the venlafaxine induced 5-HT effect in the PFC, and a moderate increase in DA levels in the HIPP. Prazosin had no significant effect on the venlafaxine-induced increase of the NA levels in PFC or HIPP. A combined treatment of venlafaxine with idazoxan increased the venlafaxine NA and DA effects in PFC by a factor of two and resulted in a very robust five-foldaugmentation of NA and DA concentrations in the HIPP. In summary, idazoxan was found to produce a potent enhancement of the venlafaxine effect to increase extracellular NA and DA levels in the PFC and, inparticular, in the HIPP. Idazoxan had no effect on venlafaxine-induced elevation of extracellular 5-HT levels in either PFC or HIPP and prazosin induced a decrease of 5-HT in the PFC. The present data suggest that blockade of ₂-adrenoreceptors may play an important role inaugmentation of the effects of mixed monoamine reuptake inhibitors.

Key Words: 2-adrenoreceptors • antidepressants • autoreceptors • hippocampus • microdialysis • monoamines • prefrontal cortex • venlafaxine

Journal of Psychopharmacology, Vol. 18, No. 3, 395-403 (2004)
DOI: 10.1177/026988110401800311


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				P. Weikop, J. Kehr, and J. Scheel-Kruger Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors J Psychopharmacol, November 1, 2007; 21(8): 795 - 804. [Abstract] [PDF]

				H. H. Hansen, C. Ebbesen, C. Mathiesen, P. Weikop, L. C. Ronn, O. Waroux, J. Scuvee-Moreau, V. Seutin, and J. D. Mikkelsen The KCNQ Channel Opener Retigabine Inhibits the Activity of Mesencephalic Dopaminergic Systems of the Rat J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1006 - 1019. [Abstract] [Full Text] [PDF]